FDG-PET/CT in infectious and inflammatory diseases

PET Clinics

Volumn 9, Issue 4, 2014, Pages 497-519

  Hess, Søren ^a   Hansson, Susanne H ^b   Pedersen, Kasper T ^a   Basu, Sandip ^c   Høilund Carlsen, Poul Flemming ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b NAESTVED HOSPITAL   (Denmark)

^c TATA MEMORIAL HOSPITAL   (India)

Author keywords

FDG; Fluorodeoxyglucose; Infection; Infectious disease; Inflammation; Inflammatory disease; PET CT; Positron emission tomography computed tomography

Indexed keywords

FLUORODEOXYGLUCOSE; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

BACTEREMIA; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HUMAN; INFECTION; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; JOINT PROSTHESIS; MEDICAL DEVICE COMPLICATION; PERIPROSTHETIC JOINT INFECTION; PSORIASIS; PYREXIA IDIOPATHICA; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SPONDYLITIS; VASCULITIS; VENOUS THROMBOEMBOLISM; BACTERIAL INFECTION; BONE DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; ENDOCARDITIS; IMMUNOCOMPROMISED PATIENT; INFLAMMATION; MICROBIOLOGY; MULTIMODAL IMAGING; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING;

ARTHRITIS, RHEUMATOID; BACTERIAL INFECTIONS; BONE DISEASES; ENDOCARDITIS; FLUORODEOXYGLUCOSE F18; HUMANS; IMMUNOCOMPROMISED HOST; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PSORIASIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RADIOPHARMACEUTICALS; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS; VENOUS THROMBOEMBOLISM;

EID: 84907577113     PISSN: 15568598     EISSN: 18799809     Source Type: Journal    
DOI: 10.1016/j.cpet.2014.07.002     Document Type: Review

References (159)

1. D.C. Knockaert, S. Vanderschueren, and D. Blockmans Fever of unknown origin in adults: 40 years on J Intern Med 253 3 2003 263 275
2. O. Israel, and Z. Keidar PET/CT imaging in infectious conditions Ann N Y Acad Sci 1228 2011 150 166
3. R. Hao, L. Yuan, and Y. Kan Diagnostic performance of 18F-FDG PET/CT in patients with fever of unknown origin: a meta-Analysis Nucl Med Commun 34 7 2013 682 688
4. H. Tokmak, O. Ergonul, and O. Demirkol Diagnostic contribution of (18)F-FDG-PET/CT in fever of unknown origin Int J Infect Dis 19 2014 53 58
5. K. Manohar, B.R. Mittal, and S. Jain F-18 FDG-PET/CT in evaluation of patients with fever of unknown origin Jpn J Radiol 31 5 2013 320 327
6. T.I. Pedersen, C. Roed, and L.S. Knudsen Fever of unknown origin: a retrospective study of 52 cases with evaluation of the diagnostic utility of FDG-PET/CT Scand J Infect Dis 44 1 2012 18 23
7. E. Pelosi, A. Skanjeti, and D. Penna Role of integrated PET/CT with [(1)(8)F]-FDG in the management of patients with fever of unknown origin: a single-centre experience Radiol Med 116 5 2011 809 820
8. J.F. Sheng, Z.K. Sheng, and X.M. Shen Diagnostic value of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with fever of unknown origin Eur J Intern Med 22 1 2011 112 116
9. J. Ferda, E. Ferdova, and J. Zahlava Fever of unknown origin: a value of (18)F-FDG-PET/CT with integrated full diagnostic isotropic CT imaging Eur J Radiol 73 3 2010 518 525
10. L. Federici, C. Blondet, and A. Imperiale Value of (18)F-FDG-PET/CT in patients with fever of unknown origin and unexplained prolonged inflammatory syndrome: a single centre analysis experience Int J Clin Pract 64 1 2010 55 60
11. P.L. Kei, T.Y. Kok, and A.K. Padhy [18F] FDG PET/CT in patients with fever of unknown origin: a local experience Nucl Med Commun 31 9 2010 788 792
12. H. Balink, J. Collins, and G.A. Bruyn F-18 FDG PET/CT in the diagnosis of fever of unknown origin Clin Nucl Med 34 12 2009 862 868
13. Z. Keidar, A. Gurman-Balbir, and D. Gaitini Fever of unknown origin: the role of 18F-FDG PET/CT J Nucl Med 49 12 2008 1980 1985
14. S. Kluge, S. Braune, and A. Nierhaus Diagnostic value of positron emission tomography combined with computed tomography for evaluating patients with septic shock of unknown origin J Crit Care 27 3 2012 316.e1 316.e7
15. T. Del Rosal, W.A. Goycochea, and A. Mendez-Echevarria F-FDG PET/CT in the diagnosis of occult bacterial infections in children Eur J Pediatr 172 8 2013 1111 1115
16. C.P. Bleeker-Rovers, F.J. Vos, and G.J. Wanten 18F-FDG PET in detecting metastatic infectious disease J Nucl Med 46 12 2005 2014 2019
17. S. Hess, S.H. Vind, and S. Skarphédinsson Clinical value of PET/CT in bacteraemia of unknown origin. Results from an observational pilot study Eur J Nucl Med Mol Imaging 37 Suppl 2 2010 1
18. F.J. Vos, C.P. Bleeker-Rovers, and B.J. Kullberg Cost-effectiveness of routine (18)F-FDG PET/CT in high-risk patients with gram-positive bacteremia J Nucl Med 52 11 2011 1673 1678
19. F.J. Vos, C.P. Bleeker-Rovers, and P.D. Sturm 18F-FDG PET/CT for detection of metastatic infection in gram-positive bacteremia J Nucl Med 51 8 2010 1234 1240
20. S.D. Guy, A.R. Tramontana, and L.J. Worth Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients Eur J Nucl Med Mol Imaging 39 8 2012 1348 1355
21. F.J. Vos, J.P. Donnelly, and W.J. Oyen 18F-FDG PET/CT for diagnosing infectious complications in patients with severe neutropenia after intensive chemotherapy for haematological malignancy or stem cell transplantation Eur J Nucl Med Mol Imaging 39 1 2012 120 128
22. M.J. O'Doherty, S.F. Barrington, and M. Campbell PET scanning and the human immunodeficiency virus-positive patient J Nucl Med 38 10 1997 1575 1583
23. C. Castaigne, M. Tondeur, and S. de Wit Clinical value of FDG-PET/CT for the diagnosis of human immunodeficiency virus-Associated fever of unknown origin: a retrospective study Nucl Med Commun 30 1 2009 41 47
24. C. Martin, C. Castaigne, and M. Tondeur Role and interpretation of fluorodeoxyglucose-positron emission tomography/computed tomography in HIV-infected patients with fever of unknown origin: a prospective study HIV Med 14 8 2013 455 462
25. M. Sathekge, A. Maes, and C. Van de Wiele FDG-PET imaging in HIV infection and tuberculosis Semin Nucl Med 43 5 2013 349 366
26. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with tuberculosis Jpn J Radiol 31 8 2013 511 520
27. M. Sathekge, A. Maes, and M. Kgomo Use of 18F-FDG PET to predict response to first-line tuberculostatics in HIV-Associated tuberculosis J Nucl Med 52 6 2011 880 885
28. V. Martinez, M.A. Castilla-Lievre, and C. Guillet-Caruba (18)F-FDG PET/CT in tuberculosis: an early non-invasive marker of therapeutic response Int J Tuberc Lung Dis 16 9 2012 1180 1185
29. R.P. Beynon, V.K. Bahl, and B.D. Prendergast Infective endocarditis BMJ 333 7563 2006 334 339
30. A. Evangelista, and M.T. Gonzalez-Alujas Echocardiography in infective endocarditis Heart 90 6 2004 614 617
31. J.S. Li, D.J. Sexton, and N. Mick Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis Clin Infect Dis 30 4 2000 633 638
32. F. Thuny, G. Di Salvo, and O. Belliard Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study Circulation 112 1 2005 69 75
33. B.C. Millar, B.D. Prendergast, and A. Alavi (18)FDG-positron emission tomography (PET) has a role to play in the diagnosis and therapy of infective endocarditis and cardiac device infection Int J Cardiol 167 5 2013 1724 1736
34. J. Van Riet, E.E. Hill, and O. Gheysens (18)F-FDG PET/CT for early detection of embolism and metastatic infection in patients with infective endocarditis Eur J Nucl Med Mol Imaging 37 6 2010 1189 1197
35. C. Ozcan, A. Asmar, and S. Gill The value of FDG-PET/CT in the diagnostic work-up of extra cardiac infectious manifestations in infectious endocarditis Int J Cardiovasc Imaging 29 7 2013 1629 1637
36. G. Williams, and G.M. Kolodny Suppression of myocardial 18F-FDG uptake by preparing patients with a high-fat, low-carbohydrate diet AJR Am J Roentgenol 190 2 2008 W151 W156
37. G. Treglia, and F. Bertagna Factors influencing the sensitivity of 18F-FDG PET/CT in the detection of infective endocarditis Eur J Nucl Med Mol Imaging 40 7 2013 1112 1113
38. G. Williams, and G.M. Kolodny Retrospective study of coronary uptake of 18F-fluorodeoxyglucose in association with calcification and coronary artery disease: a preliminary study Nucl Med Commun 30 4 2009 287 291
39. Y. Kobayashi, K. Ishii, and K. Oda Aortic wall inflammation due to Takayasu arteritis imaged with 18F-FDG PET coregistered with enhanced CT J Nucl Med 46 6 2005 917 922
40. A.A. Kaderli, I. Baran, and O. Aydin Diffuse involvement of the heart and great vessels in primary cardiac lymphoma Eur J Echocardiogr 11 1 2010 74 76
41. A. Abidov, A. D'Agnolo, and S.W. Hayes Uptake of FDG in the area of a recently implanted bioprosthetic mitral valve Clin Nucl Med 29 12 2004 848
42. L.R. Schouten, H.J. Verberne, and B.J. Bouma Surgical glue for repair of the aortic root as a possible explanation for increased F-18 FDG uptake J Nucl Cardiol 15 1 2008 146 147
43. S.H. Hong, J.Y. Choi, and J.W. Lee MR imaging assessment of the spine: infection or an imitation? Radiographics 29 2 2009 599 612
44. F. Gemmel, N. Dumarey, and C.J. Palestro Radionuclide imaging of spinal infections Eur J Nucl Med Mol Imaging 33 10 2006 1226 1237
45. R.C. Walker, L.B. Jones-Jackson, and W. Martin New imaging tools for the diagnosis of infection Future Microbiol 2 5 2007 527 554
46. M.A. Bredella, B. Essary, and M. Torriani Use of FDG-PET in differentiating benign from malignant compression fractures Skeletal Radiol 37 5 2008 405 413
47. A. Schmitz, J.H. Risse, and J. Textor FDG-PET findings of vertebral compression fractures in osteoporosis: preliminary results Osteoporos Int 13 9 2002 755 761
48. F. De Winter, F. Gemmel, and C. Van De Wiele 18-Fluorine fluorodeoxyglucose positron emission tomography for the diagnosis of infection in the postoperative spine Spine 28 12 2003 1314 1319
49. A. Guhlmann, D. Brecht-Krauss, and G. Suger Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings Radiology 206 3 1998 749 754
50. H. Zhuang, P.S. Duarte, and M. Pourdehand Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging Clin Nucl Med 25 4 2000 281 284
51. A. Guhlmann, D. Brecht-Krauss, and G. Suger Fluorine-18-FDG PET and technetium-99m antigranulocyte antibody scintigraphy in chronic osteomyelitis J Nucl Med 39 12 1998 2145 2152
52. T. Kalicke, A. Schmitz, and J.H. Risse Fluorine-18 fluorodeoxyglucose PET in infectious bone diseases: results of histologically confirmed cases Eur J Nucl Med 27 5 2000 524 528
53. M. Schiesser, K.D. Stumpe, and O. Trentz Detection of metallic implant-Associated infections with FDG PET in patients with trauma: correlation with microbiologic results Radiology 226 2 2003 391 398
54. A. Schmitz, J.H. Risse, and F. Grunwald Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results Eur Spine J 10 6 2001 534 539
55. A. Hartmann, K. Eid, and C. Dora Diagnostic value of 18F-FDG PET/CT in trauma patients with suspected chronic osteomyelitis Eur J Nucl Med Mol Imaging 34 5 2007 704 714
56. S.J. Kim, J.S. Lee, and K.T. Suh Differentiation of tuberculous and pyogenic spondylitis using double phase F-18 FDG PET Open Med Imaging J 2 2008 6
57. D. Fuster, O. Sola, and A. Soriano A prospective study comparing whole-body FDG PET/CT to combined planar bone scan with 67Ga SPECT/CT in the diagnosis of spondylodiskitis Clin Nucl Med 37 9 2012 827 832
58. T. Seifen, L. Rettenbacher, and C. Thaler Prolonged back pain attributed to suspected spondylodiscitis. The value of (1)(8)F-FDG PET/CT imaging in the diagnostic work-up of patients Nuklearmedizin 51 5 2012 194 200
59. M.L. Prodromou, P.D. Ziakas, and L.S. Poulou FDG PET is a robust tool for the diagnosis of spondylodiscitis: a meta-Analysis of diagnostic data Clin Nucl Med 39 4 2014 330 335
60. R.S. Rosen, L. Fayad, and R.L. Wahl Increased 18F-FDG uptake in degenerative disease of the spine: characterization with 18F-FDG PET/CT J Nucl Med 47 8 2006 1274 1280
61. C. Nanni, L. Boriani, and C. Salvadori FDG PET/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis Eur J Nucl Med Mol Imaging 39 10 2012 1538 1544
62. C.J. Palestro, P. Roumanas, and A.J. Swyer Diagnosis of musculoskeletal infection using combined In-111 labeled leukocyte and Tc-99m SC marrow imaging Clin Nucl Med 17 4 1992 269 273
63. S. Basu, T. Chryssikos, and S. Moghadam-Kia Positron emission tomography as a diagnostic tool in infection: present role and future possibilities Semin Nucl Med 39 1 2009 36 51
64. T.C. Kwee, R.M. Kwee, and A. Alavi FDG-PET for diagnosing prosthetic joint infection: systematic review and metaanalysis Eur J Nucl Med Mol Imaging 35 11 2008 2122 2132
65. T.K. Chacko, H. Zhuang, and K. Stevenson The importance of the location of fluorodeoxyglucose uptake in periprosthetic infection in painful hip prostheses Nucl Med Commun 23 9 2002 851 855
66. I. Uckay, K. Gariani, and Z. Pataky Diabetic foot infections: state-of-the-Art Diabetes Obes Metab 16 4 2013 305 316
67. S. Hopfner, C. Krolak, and S. Kessler Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging Foot Ankle Int 25 12 2004 890 895
68. Z. Keidar, D. Militianu, and E. Melamed The diabetic foot: initial experience with 18F-FDG PET/CT J Nucl Med 46 3 2005 444 449
69. S. Basu, T. Chryssikos, and M. Houseni Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection? Nucl Med Commun 28 6 2007 465 472
70. B. Schwegler, K.D. Stumpe, and D. Weishaupt Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB J Intern Med 263 1 2008 99 106
71. A. Nawaz, D.A. Torigian, and E.S. Siegelman Diagnostic performance of FDG-PET, MRI, and plain film radiography (PFR) for the diagnosis of osteomyelitis in the diabetic foot Mol Imaging Biol 12 3 2010 335 342
72. D. Familiari, A.W. Glaudemans, and V. Vitale Can sequential 18F-FDG PET/CT replace WBC imaging in the diabetic foot? J Nucl Med 52 7 2011 1012 1019
73. O. Kagna, S. Srour, and E. Melamed FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot Eur J Nucl Med Mol Imaging 39 10 2012 1545 1550
74. V. Ruotolo, B. Di Pietro, and L. Giurato A new natural history of Charcot foot: clinical evolution and final outcome of stage 0 Charcot neuroarthropathy in a tertiary referral diabetic foot clinic Clin Nucl Med 38 7 2013 506 509
75. J.M. Seeger Management of patients with prosthetic vascular graft infection Am Surg 66 2 2000 166 177
76. T.W. Swain 3rd, K.D. Calligaro, and M.D. Dougherty Management of infected aortic prosthetic grafts Vasc Endovascular Surg 38 1 2004 75 82
77. D.F. Orton, R.F. LeVeen, and J.A. Saigh Aortic prosthetic graft infections: radiologic manifestations and implications for management Radiographics 20 4 2000 977 993
78. K. Fukuchi, Y. Ishida, and M. Higashi Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings J Vasc Surg 42 5 2005 919 925
79. Z. Keidar, A. Engel, and A. Hoffman Prosthetic vascular graft infection: the role of 18F-FDG PET/CT J Nucl Med 48 8 2007 1230 1236
80. M. Spacek, O. Belohlavek, and J. Votrubova Diagnostics of "on-Acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses Eur J Nucl Med Mol Imaging 36 5 2009 850 858
81. J.L. Bruggink, A.W. Glaudemans, and B.R. Saleem Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection Eur J Vasc Endovasc Surg 40 3 2010 348 354
82. A.S. Krupnick 81-Fluorodeoxyglucose positron emission tomography as a novel imaging tool for the diagnosis of aortoenteric fistula and aortic graft infection: a case report Vasc Endovascular Surg 37 5 2003 363 366
83. D. Blockmans, L. de Ceuninck, and S. Vanderschueren Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients Arthritis Rheum 55 1 2006 131 137
84. C.P. Bleeker-Rovers, S.J. Bredie, and J.W. van der Meer F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis Neth J Med 61 10 2003 323 329
85. I. Zerizer, K. Tan, and S. Khan Role of FDG-PET and PET/CT in the diagnosis and management of vasculitis Eur J Radiol 73 3 2010 504 509
86. S. Basu, H. Zhuang, and D.A. Torigian Functional imaging of inflammatory diseases using nuclear medicine techniques Semin Nucl Med 39 2 2009 124 145
87. M.A. Walter, R.A. Melzer, and C. Schindler The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease Eur J Nucl Med Mol Imaging 32 6 2005 674 681
88. G. Treglia, M.V. Mattoli, and L. Leccisotti Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with large-vessel vasculitis: a systematic review Clin Rheumatol 30 10 2011 1265 1275
89. K.H. Lee, A. Cho, and Y.J. Choi The role of (18) F-fluorodeoxyglucose-positron emission tomography in the assessment of disease activity in patients with Takayasu arteritis Arthritis Rheum 64 3 2012 866 875
90. M. Webb, A. Chambers, and A. AL-Nahhas The role of 18F-FDG PET in characterising disease activity in Takayasu arteritis Eur J Nucl Med Mol Imaging 31 5 2004 627 634
91. G. Treglia, S. Taralli, and A. Giordano Emerging role of whole-body 18F-fluorodeoxyglucose positron emission tomography as a marker of disease activity in patients with sarcoidosis: a systematic review Sarcoidosis Vasc Diffuse Lung Dis 28 2 2011 87 94
92. G. Rubini, S. Cappabianca, and C. Altini Current clinical use of FDG-PET/CT in patients with thoracic and systemic sarcoidosis Radiol Med 119 1 2014 64 74
93. V. Ambrosini, M. Zompatori, and L. Fasano (18)F-FDG PET/CT for the assessment of disease extension and activity in patients with sarcoidosis: results of a preliminary prospective study Clin Nucl Med 38 4 2013 e171 e177
94. R.G. Keijsers, D.A. van den Heuvel, and J.C. Grutters Imaging the inflammatory activity of sarcoidosis Eur Respir J 41 3 2013 743 751
95. A.S. Teirstein, J. Machac, and O. Almeida Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis Chest 132 6 2007 1949 1953
96. D. Valeyre, A. Prasse, and H. Nunes Sarcoidosis Lancet 383 9923 2014 1155 1167
97. A.W. Glaudemans, E.F. de Vries, and F. Galli The use of (18)F-FDG-PET/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases Clin Dev Immunol 2013 2013 623036
98. R.G. Keijsers, E.J. Verzijlbergen, and J.M. van den Bosch 18F-FDG PET as a predictor of pulmonary function in sarcoidosis Sarcoidosis Vasc Diffuse Lung Dis 28 2 2011 123 129
99. D. Sobic-Saranovic, I. Grozdic, and J. Videnovic-Ivanov The utility of 18F-FDG PET/CT for diagnosis and adjustment of therapy in patients with active chronic sarcoidosis J Nucl Med 53 10 2012 1543 1549
100. D.P. Sobic-Saranovic, I.T. Grozdic, and J. Videnovic-Ivanov Responsiveness of FDG PET/CT to treatment of patients with active chronic sarcoidosis Clin Nucl Med 38 7 2013 516 521
101. R.L. Mostard, S. Voo, and M.J. van Kroonenburgh Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis Respir Med 105 12 2011 1917 1924
102. G. Youssef, E. Leung, and I. Mylonas The use of 18F-FDG PET in the diagnosis of cardiac sarcoidosis: a systematic review and metaanalysis including the Ontario experience J Nucl Med 53 2 2012 241 248
103. H. Ohira, I. Tsujino, and K. Yoshinaga (1)(8)F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis Eur J Nucl Med Mol Imaging 38 9 2011 1773 1783
104. H. Skali, A.R. Schulman, and S. Dorbala 18F-FDG PET/CT for the assessment of myocardial sarcoidosis Curr Cardiol Rep 15 4 2013 352
105. B.M. Segal Neurosarcoidosis: diagnostic approaches and therapeutic strategies Curr Opin Neurol 26 3 2013 307 313
106. K. Sakushima, I. Yabe, and T. Shiga FDG-PET SUV can distinguish between spinal sarcoidosis and myelopathy with canal stenosis J Neurol 258 2 2011 227 230
107. S.B. Perlman, B.S. Hall, and M. Reichelderfer PET/CT imaging of inflammatory bowel disease Semin Nucl Med 43 6 2013 420 426
108. I. Bicik, P. Bauerfeind, and T. Breitbach Inflammatory bowel disease activity measured by positron-emission tomography Lancet 350 9073 1997 262
109. M.F. Neurath, D. Vehling, and K. Schunk Noninvasive assessment of Crohn's disease activity: a comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies Am J Gastroenterol 97 8 2002 1978 1985
110. G. Treglia, N. Quartuccio, and R. Sadeghi Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in patients with chronic inflammatory bowel disease: a systematic review and a meta-Analysis J Crohns Colitis 7 5 2013 345 354
111. F. Lenze, J. Wessling, and J. Bremer Detection and differentiation of inflammatory versus fibromatous Crohn's disease strictures: prospective comparison of 18F-FDG-PET/CT, MR-enteroclysis, and transabdominal ultrasound versus endoscopic/histologic evaluation Inflamm Bowel Dis 18 12 2012 2252 2260
112. H.A. Jacene, P. Ginsburg, and J. Kwon Prediction of the need for surgical intervention in obstructive Crohn's disease by 18F-FDG PET/CT J Nucl Med 50 11 2009 1751 1759
113. R.T. Lapp, B.J. Spier, and S.B. Perlman Clinical utility of positron emission tomography/computed tomography in inflammatory bowel disease Mol Imaging Biol 13 3 2011 573 576
114. D. Groshar, H. Bernstine, and D. Stern PET/CT enterography in Crohn disease: correlation of disease activity on CT enterography with 18F-FDG uptake J Nucl Med 51 7 2010 1009 1014
115. C.J. Das, G. Makharia, and R. Kumar PET-CT enteroclysis: a new technique for evaluation of inflammatory diseases of the intestine Eur J Nucl Med Mol Imaging 34 12 2007 2106 2114
116. C.J. Das, G.K. Makharia, and R. Kumar PET/CT colonography: a novel non-invasive technique for assessment of extent and activity of ulcerative colitis Eur J Nucl Med Mol Imaging 37 4 2010 714 721
117. D. Bettenworth, S. Reuter, and S. Hermann Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation J Nucl Med 54 5 2013 748 755
118. R.S. Meisner, B.J. Spier, and S. Einarsson Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease Inflamm Bowel Dis 13 8 2007 993 1000
119. E. Louis, G. Ancion, and A. Colard Noninvasive assessment of Crohn's disease intestinal lesions with (18)F-FDG PET/CT J Nucl Med 48 7 2007 1053 1059
120. B.J. Spier, S.B. Perlman, and C.J. Jaskowiak PET/CT in the evaluation of inflammatory bowel disease: studies in patients before and after treatment Mol Imaging Biol 12 1 2010 85 88
121. M.H. Malham, R.G. Nielse, and S. Husby PET/CT in the diagnosis of inflammatory bowel disease in pediatric patients: a review Am J Nucl Med Mol Imaging 4 3 2014 225 230
122. A. Bockisch, L.S. Freudenberg, and D. Schmidt Hybrid imaging by SPECT/CT and PET/CT: proven outcomes in cancer imaging Semin Nucl Med 39 4 2009 276 289
123. J. Czernin, M. Allen-Auerbach, and H.R. Schelbert Improvements in cancer staging with PET/CT: literature-based evidence as of 2006 J Nucl Med 48 Suppl 1 2007 78S 88S
124. K. Facey, I. Bradbury, and G. Laking Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers Health Technol Assess 11 44 2007 iii iv xi-267
125. S.N. Histed, M.L. Lindenberg, and E. Mena Review of functional/anatomical imaging in oncology Nucl Med Commun 33 4 2012 349 361
126. B. Saboury, A. Salavati, and A. Brothers FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity Eur J Nucl Med Mol Imaging 41 4 2014 605 614
127. M. Yun, W. Kim, and L.E. Adam F-18 FDG uptake in a patient with psoriatic arthritis: imaging correlation with patient symptoms Clin Nucl Med 26 8 2001 692 693
128. T. Takata, Y. Taniguchi, and T. Ohnishi (18)FDG PET/CT is a powerful tool for detecting subclinical arthritis in patients with psoriatic arthritis and/or psoriasis vulgaris J Dermatol Sci 64 2 2011 144 147
129. E.D. Harris Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy N Engl J Med 322 18 1990 1277 1289
130. K. Carey, B. Saboury, and S. Basu Evolving role of FDG PET imaging in assessing joint disorders: a systematic review Eur J Nucl Med Mol Imaging 38 10 2011 1939 1955
131. C. Beckers, C. Ribbens, and B. Andre Assessment of disease activity in rheumatoid arthritis with (18)F-FDG PET J Nucl Med 45 6 2004 956 964
132. M. Sarma, V. Vijayant, and S. Basu (18)F-FDG-PET assessment of early treatment response of articular and extra-Articular foci in newly diagnosed rheumatoid arthritis Hell J Nucl Med 15 1 2012 70 71
133. V. Vijayant, M. Sarma, and H. Aurangabadkar Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies World J Radiol 4 12 2012 462 468
134. S. Basu, and Y. Shejul Regional lymph node hypermetabolism corresponding to the involved joints on FDG-PET in newly diagnosed patients of rheumatoid arthritis: observation and illustration in symmetrical and asymmetric joint involvement Rheumatol Int 34 3 2014 413 415
135. A. Roivainen, S. Hautaniemi, and T. Mottonen Correlation of 18F-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs Eur J Nucl Med Mol Imaging 40 3 2013 403 410
136. K. Okamura, Y. Yonemoto, and Y. Arisaka The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT Rheumatology 51 8 2012 1484 1491
137. N.N. Mehta, Y. Yu, and B. Saboury Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study Arch Dermatol 147 9 2011 1031 1039
138. S. Rose, N.H. Sheth, and J.F. Baker A comparison of vascular inflammation in psoriasis, rheumatoid arthritis, and healthy subjects by FDG-PET/CT: a pilot study Am J Cardiovasc Dis 3 4 2013 273 278
139. J.M. Gelfand, A.L. Neimann, and D.B. Shin Risk of myocardial infarction in patients with psoriasis JAMA 296 14 2006 1735 1741
140. M.J. Roman, and J.E. Salmon Cardiovascular manifestations of rheumatologic diseases Circulation 116 20 2007 2346 2355
141. R. Bissonnette, J.C. Tardif, and F. Harel Effects of the tumor necrosis factor-Alpha antagonist adalimumab on arterial inflammation assessed by positron emission tomography in patients with psoriasis: results of a randomized controlled trial Circ Cardiovasc Imaging 6 1 2013 83 90
142. P.H. Madsen, S. Hess, and P.F. Hoilund-Carlsen Positron emission tomography in chronic obstructive pulmonary disease Hell J Nucl Med 16 2 2013 121 124
143. H.A. Jones, P.S. Marino, and B.H. Shakur In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma Eur Respir J 21 4 2003 567 573
144. D.R. Subramanian, L. Jenkins, and R. Edgar Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography Am J Respir Crit Care Med 186 11 2012 1125 1132
145. J.M. Coulson, J.H. Rudd, and J.M. Duckers Excessive aortic inflammation in chronic obstructive pulmonary disease: an 18F-FDG PET pilot study J Nucl Med 51 9 2010 1357 1360
146. S. Basu, S. Alzeair, and G. Li Etiopathologies associated with intercostal muscle hypermetabolism and prominent right ventricle visualization on 2-deoxy-2[F-18]fluoro-D-glucose-positron emission tomography: significance of an incidental finding and in the setting of a known pulmonary disease Mol Imaging Biol 9 6 2007 333 339
147. A. Aydin, M. Hickeson, and J.Q. Yu Demonstration of excessive metabolic activity of thoracic and abdominal muscles on FDG-PET in patients with chronic obstructive pulmonary disease Clin Nucl Med 30 3 2005 159 164
148. 18F-FDG uptake by respiratory muscles on PET/CT correlate with chronic obstructive pulmonary disease? J Nucl Med Technol 39 4 2011 252 257
149. D.A. Torigian, V. Dam, and X. Chen In vivo quantification of pulmonary inflammation in relation to emphysema severity via partial volume corrected (18)F-FDG-PET using computer-Assisted analysis of diagnostic chest CT Hell J Nucl Med 16 1 2013 12 18
150. S. Hess, P.H. Madsen, and S. Basu Potential role of FDG PET/CT imaging for assessing venous thromboembolic disorders Clin Nucl Med 37 12 2012 1170 1172
151. S. Hess, P.H. Madsen, and E.D. Iversen Efficacy of FDG-PET/CT imaging for venous thromboembolic disorders: preliminary results from a prospective, observational pilot study Clin Nucl Med 2014 [Epub ahead of print]
152. M.T. Rondina, U.T. Lam, and R.C. Pendleton (18)F-FDG PET in the evaluation of acuity of deep vein thrombosis Clin Nucl Med 37 12 2012 1139 1145
153. M.T. Rondina, N. Wanner, and R.C. Pendleton A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism Thromb Res 129 1 2012 22 27
154. P. Hunziker "Knowledge-based (personalized) medicine" instead of "evidence-based (cohort) medicine" Eur J Nanomed 4 1 2012 5 6
155. S.J. Skehan, R. Issenman, and J. Mernagh 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease Lancet 354 1999 836 837
156. D.A. Lemberg, R.M. Issenman, and R. Cawdron Positron emission tomography in the investigation of pediatric inflammatory bowel disease Inflamm Bowel Dis 11 2005 733 738
157. M. Loffler, M. Weckesser, and C. Franzius High diagnostic value of 18F-FDG-PET in pediatric patients with chronic inflammatory bowel disease Ann N Y Acad Sci 1072 2006 379 385
158. J. Dabritz, N. Jasper, and M. Loeffler Noninvasive assessment of pediatric inflammatory bowel disease with 18-F-fluorodeoxyglucose-positron emission tomography and computed tomography Eur J Gastroenterol Hepatol 23 1 2011 81 89
159. L.D. Berthold, D. Steiner, and D. Scholz Imaging of chronic inflammatory bowel disease with 18F-FDG PET in children and adolescents Klin Padiatr 225 2013 212 217